{"id":"https://openalex.org/W7225747059","doi":"https://doi.org/10.25251/s8yn8r04","title":"One-year acne tolerability of abrocitinib versus upadacitinib in moderate-to-severe atopic dermatitis: an unanchored matching-adjusted indirect comparison","display_name":"One-year acne tolerability of abrocitinib versus upadacitinib in moderate-to-severe atopic dermatitis: an unanchored matching-adjusted indirect comparison","publication_year":2026,"publication_date":"2026-11-10","ids":{"openalex":"https://openalex.org/W7225747059","doi":"https://doi.org/10.25251/s8yn8r04"},"language":"en","primary_location":{"id":"doi:10.25251/s8yn8r04","doi":"https://doi.org/10.25251/s8yn8r04","is_oa":true,"landing_page_url":"https://doi.org/10.25251/s8yn8r04","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.25251/s8yn8r04","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5161364628","display_name":"Stephen Weidinger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen Weidinger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020785070","display_name":"Christopher G. Bunick","orcid":"https://orcid.org/0000-0002-4011-8308","observed_orcids":["https://orcid.org/0000-0002-4011-8308"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher G. Bunick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160193017","display_name":"Alan Irvine","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan Irvine","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066385470","display_name":"Hwanhee Hong","orcid":"https://orcid.org/0000-0002-3736-6327","observed_orcids":["https://orcid.org/0000-0002-3736-6327"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Chih-ho Hong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161363606","display_name":"Howard Thom","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Howard Thom","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159345876","display_name":"Philip Orishaba","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philip Orishaba","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042319336","display_name":"David Aceituno","orcid":"https://orcid.org/0000-0002-2967-5816","observed_orcids":["https://orcid.org/0000-0002-2967-5816"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Aceituno","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040405517","display_name":"Ernest H. Law","orcid":"https://orcid.org/0000-0002-6111-8008","observed_orcids":["https://orcid.org/0000-0002-6111-8008"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ernest H. Law","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000559088","display_name":"Samantha K. Kurosky","orcid":"https://orcid.org/0000-0003-2392-8111","observed_orcids":["https://orcid.org/0000-0003-2392-8111"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samantha K. Kurosky","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057331493","display_name":"Herwig Koppensteiner","orcid":"https://orcid.org/0009-0004-4228-7553","observed_orcids":["https://orcid.org/0009-0004-4228-7553"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Herwig Koppensteiner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5128668182","display_name":"Simon Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Simon Chen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"6","first_page":"s846","last_page":"s846"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8903999924659729},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7138000130653381},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6395999789237976},{"id":"https://openalex.org/C2777673923","wikidata":"https://www.wikidata.org/wiki/Q79928","display_name":"Acne","level":2,"score":0.5758000016212463},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5455999970436096},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4697999954223633},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.4228000044822693},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4124000072479248},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.3962000012397766},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.32339999079704285},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.29670000076293945},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.28870001435279846},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.28439998626708984}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.25251/s8yn8r04","doi":"https://doi.org/10.25251/s8yn8r04","is_oa":true,"landing_page_url":"https://doi.org/10.25251/s8yn8r04","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.25251/s8yn8r04","doi":"https://doi.org/10.25251/s8yn8r04","is_oa":true,"landing_page_url":"https://doi.org/10.25251/s8yn8r04","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Introduction:":[0],"Janus":[1],"kinase":[2],"inhibitors":[3],"(JAKi),":[4],"including":[5],"abrocitinib":[6,83,92,168,195,229,244,267,282,298,341,354,369],"and":[7,19,39,55,79,104,107,116,202,238,276,295,324,332,343,389,393],"upadacitinib,":[8],"are":[9],"effective":[10,352],"systemic":[11],"therapies":[12],"for":[13,73,155,165,314,384],"moderate-to-severe":[14],"atopic":[15],"dermatitis":[16],"(M2S":[17],"AD)":[18],"have":[20],"demonstrated":[21,299],"superiority":[22],"to":[23,68,181],"dupilumab.":[24],"Acne":[25,43],"is":[26,44],"a":[27,45,300,358,374],"notable":[28],"JAKi":[29,316],"class-level":[30],"adverse":[31,47],"event":[32,48],"observed":[33],"across":[34],"randomized":[35],"clinical":[36,41],"trials":[37],"(RCTs)":[38],"real-world":[40],"practice.":[42],"burdensome":[46],"that":[49],"can":[50],"undermine":[51],"treatment":[52,159,185,348],"adherence,":[53],"persistence,":[54],"satisfaction":[56],"in":[57,130,318],"patients":[58,125,192,204,385],"with":[59,77,167,194,206,224,239,262,277,329,340,349],"M2S":[60,319],"AD.":[61,320],"The":[62],"objective":[63],"of":[64,75,82,89,141,184,219,222,257,260,337],"this":[65],"study":[66,134,398],"was":[67,217,255,399],"provide":[69],"indirect":[70,150],"comparative":[71],"data":[72],"risk":[74],"acne":[76,166,223,261,303,338,361],"high":[78],"low":[80],"doses":[81],"versus":[84,173,228,243,266,281,306],"upadacitinib":[85,109,174,207,225,240,263,278,307,322,365,379],"over":[86,333],"1":[87,97,114,182,309],"year":[88,183],"treatment.Methods:":[90],"Four":[91],"monotherapy":[93,110],"RCTs":[94,111],"(JADE":[95],"MONO":[96,99],"[NCT03349060],":[98],"2":[100,108,119],"[NCT03575871],":[101],"MOA":[102],"[NCT03915496],":[103],"EXTEND":[105,136],"[NCT03422822])":[106],"(Measure":[112],"Up":[113,118,143],"[NCT03569293]":[115],"Measure":[117,142],"[NCT03607422])":[120],"were":[121,145,153,186,214,327],"included.":[122,147,215],"Placebo":[123],"crossover":[124],"who":[126,386],"later":[127],"received":[128],"abrocitinib/upadacitinib":[129],"the":[131,350],"long-term":[132,138,315],"extension":[133,139],"JADE":[135],"or":[137,170,176,381],"periods":[140],"1/2":[144],"also":[146],"Standard":[148],"matching-adjusted":[149],"comparison":[151],"methods":[152],"used":[154],"adjustments":[156],"based":[157],"on":[158],"effect":[160],"modifiers.":[161],"Odds":[162],"ratios":[163],"(OR)":[164],"(200":[169],"100":[171,245,268,344,355],"mg)":[172,178],"(30":[175],"15":[177,241,279,325,366,382],"after":[179],"up":[180],"calculated.":[187],"Results:":[188],"Data":[189],"from":[190],"774":[191],"treated":[193,205],"(100":[196],"mg,":[197,200,209,212,345,367],"n=431;":[198],"200":[199,230,283,342,370],"n=343)":[201],"1608":[203],"(15":[208],"n=797;":[210],"30":[211,226,264,323,380],"n=811)":[213],"There":[216],"evidence":[218,256],"higher":[220,258,335],"odds":[221,259,336],"mg":[227,231,242,246,265,269,280,284,326,356,371,383],"(OR":[232,247,270,285],"[95%":[233,248,271,286],"CI],":[234,249,272,287],"3.39":[235],"[2.14-5.36];":[236],"P<0.0001),":[237,275],"7.72":[250],"[3.72-16.01];":[251],"P<0.0001).":[252],"Similarly,":[253],"there":[254],"13.21":[273],"[6.41-27.21];":[274],"1.98":[288],"(1.24-3.16);":[289],"P=0.0045).":[290],"Conclusions:":[291],"Across":[292],"both":[293],"matched-":[294],"cross-dose":[296],"comparisons,":[297],"consistently":[301],"favorable":[302],"tolerability":[304],"profile":[305,363],"at":[308],"year\u2014a":[310],"clinically":[311],"meaningful":[312],"consideration":[313],"selection":[317],"Notably,":[321],"associated":[328],"nearly":[330],"3.5\u00d7,":[331],"7.5\u00d7":[334],"compared":[339],"respectively.":[346],"For":[347],"lowest":[351],"dose,":[353],"has":[357],"more":[359,375],"tolerable":[360,376],"safety":[362],"than":[364,378],"while":[368],"may":[372],"be":[373],"option":[377],"require":[387],"fast":[388],"durable":[390],"skin":[391],"clearance":[392],"itch":[394],"relief.":[395],"Funding:":[396],"This":[397],"sponsored":[400],"by":[401],"Pfizer.":[402]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-11T00:00:00"}